Cargando…
Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
This report describes a case of a male infant diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who was prescribed favipiravir therapy. The mother noticed a discoloration of the child's eyes within 18 h of therapy, and the cornea returned to normal color with...
Autores principales: | Jiravisitkul, Paveewan, Thonginnetra, Saraiorn, Wongvisavavit, Rintra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154467/ https://www.ncbi.nlm.nih.gov/pubmed/37152312 http://dx.doi.org/10.3389/fped.2023.1154814 |
Ejemplares similares
-
Supporting factors and structural barriers in the continuity of breastfeeding in the hospital workplace
por: Jiravisitkul, Paveewan, et al.
Publicado: (2022) -
An unusual case of bluish discoloration of the cornea after favipiravir therapy for COVID-19
por: Raiturcar, Tanvi P, et al.
Publicado: (2021) -
A man with pain and bluish discoloration of left arm
por: Almanza‐Hurtado, Amilkar, et al.
Publicado: (2021) -
Challenges in corneal endothelial cell culture
por: Wongvisavavit, Rintra, et al.
Publicado: (2021) -
Unilateral Bluish Sclera
por: Hari Kumar, K. V. S., et al.
Publicado: (2018)